Notice: Prescription Drug List (PDL): Hyoscine butylbromide

The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use by adding it to the Human Prescription Drug List (PDL). Injectable Hyoscine butylbromide is already listed on the Veterinary Prescription Drug List.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis : Liste des drogues sur ordonnance (LDO) : Butylbromure d-hyoscine
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["avis de modification", "Liste des drogues sur ordonnance", "LPD", "Bromure de butyle d'hyoscine injectable", "statut de prescription", "statut éthique", "usage humain", "PDL humaine"], "en": ["notice of amendment", "Prescription Drug List", "PDL", "injectable Hyoscine butylbromide", "prescription status", "ethical status", "human use", "Human PDL"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source